Lantern Pharma has won a trio of rare-pediatric-disease designations from the Food and Drug Administration for its investigational drug candidate LP-184 in multiple ultra-rare children's cancers.

We found that some rare magma types are surprisingly efficient at concentrating rare earth elements. This is a group of metals with crucial applications in several high-tech industries ...

Cross country has been one of the school’s most successful sports. North Star won the LPS meet with 32 points. Lincoln East finished second with 53 and Lincoln Southwest was third. North Star ...

A G3 magnetic storm is forecasted by the Space Weather Prediction branch of the National Oceanic and Atmospheric Administration (NOAA) for Friday. In Pennsylvania and New Jersey, the G3 storm will ...

A mysterious type of iron-rich magma entombed within extinct volcanoes is likely abundant with rare earth elements and could offer a new way to source these in-demand metals, according to new ...

LPS also holds a number of public hearings each budget cycle. This year, LPS is looking to raise its property tax request by 9%, or $31 million, to help cover a $32 million state aid deficit the ...

— Recommendations are independently chosen by our editors. Purchases you make through our links may earn us and our publishing partners a commission. The 2023 Meta Quest 3 is the brand's newest ...

De Lima’s co-nominees are former Reps. Teddy Baguilat and Erin Tañada. Their candidacy was announced during the LP’s national executive council meeting held at Club Filipino in San Juan City ...

Scientists have discovered an ultra-rare particle decay process, opening a new path to find physics beyond our understanding of how the building blocks of matter interact. Scientists at CERN have ...

Those conditions, I reasoned, were rare. How people think about rare events—especially unwelcome ones such as traumatic medical episodes or distressing diagnoses—seems to vary considerably ...

The FDA has granted 3 rare pediatric disease designations (RPDD) to the investigational agent LP-184 in malignant rhabdoid tumors, rhabdomyosarcoma, and hepatoblastoma. LP-184 previously earned a RPDD ...